Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Clinical Development

S R Pharma financial results reflect siRNA plans

29-Sep-2005 - S R Pharma have released its interim results for the first half of 2005, which show the continued consolidation of Research and Development costs as resources were diverted to acquire...

Celtic Pharma declares Transfersome carrier interest

28-Sep-2005 - Celtic Pharma has announced the acquisition of a stake in IDEA - a biopharma company, which is developing targeted therapeutics based on novel, Transfersome carriers that can increase drug potency...

Genzyme unveils $540m expansion plan for manufacturing, R&D

27-Sep-2005 - US biotechnology major Genzyme officially opened four European facilities last week as part of a investment package eventually expected to cost $540 million (€449m).

Advanced Biosciences takes sales into own hands

27-Sep-2005 - The Advanced Biosciences division of US specialty materials maker Rohm and Haas has decided to sell its entire range of solutions for the production of biopharmaceuticals directly to customers.

IVD market set to explode in Europe

27-Sep-2005 - New discoveries and innovative technologies will create growth opportunities in the in-vitro diagnostics (IVD) market with molecular diagnostic assays set to feature strongly in the development of personalised medicine and...

New lab system allows macromolecule analysis

27-Sep-2005 - PANalytical has added a new focusing mirror to its range of PreFIX optics that for the first time, can analyse macromolecules using a standard, laboratory-based XRD system, rather than on...

DecisionNews Media seeks pharma industry reporter

27-Sep-2005 - DecisionNews Media is seeking a further reporter for its pharmaceuticals industry news services. Applicants must be exceptionally bright, ambitious and talented, with experience in news writing on the pharmaceuticals industry.

Gerresheimer expands in US and China with GGI purchase

26-Sep-2005 - German packaging company Gerresheimer has announced plans to take over the pharmaceutical business of troubled Glass Group Inc (GGI) of the US, after a Delaware bankruptcy court approved the transaction.

Galapagos and BioFocus forms new biopharma outfit

26-Sep-2005 - Galapagos has announced that its acquisition of BioFocus' would accelerate its transition to a fully integrated drug development biopharmaceutical company after the two companies reached agreement on the terms of...

Celsis, BioVentures team up on contamination detection

22-Sep-2005 - Celsis International has signed a collaboration with BioVentures to develop a microarray-based microbiological testing system to detect contamination in pharmaceutical, biotechnology and other process industries.

Eisai taps India for manufacturing expertise

21-Sep-2005 - Eisai has become the first Japanese drugmaker to set up a dedicated subsidiary in India in order to tap into local expertise in manufacturing and research, according to local press...

Euroscreen awarded US patent on GPC receptor

21-Sep-2005 - Euroscreen has announced the issuance of a US patent, which covers the use of a human G-protein-coupled receptor (GPCR) human P2Y13. The patent protects screening processes using this receptor to...

Biotrace expands in pharma with MicroSafe acquisition

20-Sep-2005 - Biotrace of the UK has acquired MicroSafe Group, an Italian supplier of microbiological testing products for the pharmaceutical, food and defence sectors, for £2.5 million.

Zentiva buys Sicomed in latest generics M&A

20-Sep-2005 - The consolidation in the generic pharmaceutical industry continues apace, with companies in the easterly reaches of Europe now getting in on the act. Czech Republic-headquartered Zentiva has signed an agreement...

MerLion and CRT in UK-Asia cancer deal.

20-Sep-2005 - MerLion Pharmaceuticals has entered into a large-scale screening programme with Cancer Research Technology (CRT) to identify new anti-cancer drug candidates derived from natural product chemistry.

KemFine buys Avecia Fine Chemicals

19-Sep-2005 - KemFine, the fine chemicals business created via a management buyout from chemicals group Kemira last year, has acquired Avecia Fine Chemicals' business based in Grangemouth, Scotland.

Cleanroom company Esco opens doors in US

19-Sep-2005 - Singapore-based cleanroom specialist Esco has set up its first direct presence in the US market via the opening of a new subsidiary, Esco Technologies, based in Philadelphia.

Bodycote adds to pharma services with Cirrus buy

16-Sep-2005 - UK pharmaceutical testing company Cirrus Laboratories has been acquired by Bodycote Materials Testing, an international provider of materials testing services to industry.

MedImmune purchases Cellective Therapeutics

16-Sep-2005 - Medimmune announced the signing of an agreement to acquire Cellective Therapeutics, in a deal that furthers its strategy of increasing new drug candidates in its specialist areas of cancer and...

Report sees boom time ahead for biopharma CMOs

15-Sep-2005 - Pharmaceutical companies are increasingly looking to retain their internal focus on research and development (R&D) and marketing while outsourcing their manufacturing processes, thus fueling a growing demand for the manufacturing...

European firm eyes BioSante's nanoparticle technology

15-Sep-2005 - BioSante Pharmaceuticals has licensed its calcium phosphate (CaP) nanotechnology - used for drug delivery and as an adjuvant for vaccines - to an unnamed European pharmaceutical company.

After US, Indian packager eyes European market

14-Sep-2005 - India's largest pharmaceutical packaging company, Bilcare, is planning to open a subsidiary in Germany, shortly after announcing a major acquisition in the US, in a move that underlines its international...

Lonza hikes API production capacity

13-Sep-2005 - Switzerland's Lonza has boosted its ability to make active pharmaceutical ingredients (API) at its Visp site in response to what it said was 'ever increasing hygienic and regulatory requirements'.

Ambion and Rosetta in microRNA deal

13-Sep-2005 - Ambion and Rosetta Genomics have announced a licensing and commercialisaton agreement to advance microRNA research. The results will facilitate microRNA research that hails this as a promising area in the...

MorphoSys announces agreement with Shionogi

09-Sep-2005 - Biotechnology firm, MorphoSys, have announced an agreement with pharmaceutical company Shionogi, in a deal that fits into MorphoSys' effort to expand geographically into the Japanese market - currently the second...

Key Industry Events